News

Rx Name Unethical Practitioners: A medical thriller unfolds in India
India's Department of Pharmaceuticals found AbbVie Healthcare India sponsored ₹1.91 crore in international trips for 30 ...
Clinical Trials Arena7h
AbbVie’s Phase III trial of atogepant for migraine meets primary goal
AbbVie has announced that its Phase III TEMPLE study, which compared atogepant to topiramate for migraine, has met its ...
Investing Snacks8h
AbbVie’s Migraine Drug Passes Key Phase 3 Test
AbbVie’s migraine drug Atogepant just cleared a major Phase 3 hurdle, and it’s got Wall Street rubbing its temples—in ...
PharmiWeb10h
A Successful Year of Collaboration: AbbVie Golden Ticket Comes to a Close
AbbVie Golden Ticket Comes to a ClosePress release2025-06-18 11:48AbbVie Golden Ticket ceremony at SmiLe Venture Hub.Lund, Sweden – The one-year AbbVie Golden Ticket program has officially concluded – ...